- Biotech funding optimism rises as 44% predict recovery in 2024 Pharmaceutical Technology
- Biotech continues to demonstrate dependable growth with a cyclical boost FE Trustnet
- Neuroscience renaissance leads to new crop of psychiatric drugs STAT
- Biotech Stocks Are on a Tear. They Could Keep Climbing. Barron’s
- Resilience amidst uncertainty in biotech: A Q&A with BB Biotech’s Dr Daniel Koller IFA Magazine
Recent Comments